Business
Press Release Feb 13 2026
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release - Acrotech Biopharma Inc., Announces FDA Approval of ADQUEY (difamilast 1%) Ointment for the Treatment of Mild-to-Moderate Atopic Dermatitis".
About this update from Aurobindo Pharma Ltd
[{"type":"text","content":" Aurobindo Pharma Limited has informed the Exchange regarding a press release dated February 13, 2026, titled \"Press Release - Acrotech Biopharma Inc., Announces FDA Approval of ADQUEY (difamilast 1%) Ointment for the Treatment of Mild-to-Moderate Atopic Dermatitis\". View Attachment","length":446,"tagName":"div"}]